The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

Paxneury and Tuzulby should be granted Europe-wide marketing authorizations for treating attention-deficit hyperactivity, the ...

(RTTNews) - Biohaven Ltd. (BHVN), Monday announced several clinical and regulatory milestones across its proprietary Molecular Degrader of Extracellular Proteins platform as well as its glutamate ...

Objective: To compare the haemodynamic effects of nebivolol, a highly selective antagonist of 1-adrenergic receptors with additional actions caused via the L-arginine/nitric oxide pathway ...

Alpha-1 adrenergic receptor antagonist (α1-ARA) are well established treatment for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS). Since BPH and erectile dysfunction ...

β-adrenergic receptors (β-ARs) play a critical role in modulating learning, memory, emotionality, and long-term synaptic plasticity. Recent studies indicate that β-ARs are necessary for long-term ...

Exicure, Inc. (Nasdaq: XCUR, “Exicure”, “the Company”), has announced the signing of a Memorandum of Understanding (MOU) with ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 URO-901-3005 trial.

Brian Kobilka of Stanford University became fascinated by adrenergic receptors, a family of GPCRs that respond to adrenalin, when he completed his medical residency. “So many of the drugs we ...

MEDICATIONS taken by thousands of Brits for to treat an overactive bladder have been linked to dementia in a new study. Some forms of the medication have been found to raise the risk of dementia ...

About Rapiblyck TM (landiolol) intravenous [280 mg of landiolol (equivalent to 300 mg of landiolol HCl) in a single-dose vial ...

This increase in flow is mediated through local metabolic mechanisms and partially through adrenergic receptor mediated vasomotion. This review will focus specifically on the role played by the ...